🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

RecruitingNAAges 18 Years - anyAllUniversity of Tennessee Medical Center
NCT05024344 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM. * Female participants of childbearing potential will be required to provide a negative pregnancy test. * Ability to understand and teach back consent for the procedure. * Willingness to sign consent for procedure. * English speaking. Exclusion Criteria: * Emergent surgery status. * Local infection * Allergy to local anesthetics. * Recreational drug use. * Inability to provide informed consent. * Pregnancy or breastfeeding. * History of Guillain-Barre' Syndrome. * Underlying medical conditions that would post a significant risk to the patient. * Opioid use \>90 days in the year leading up to surgery.
💊

What it tests

  • Erector Spinae Plane Block
  • Ropivacaine 0.5% Injectable Solution
  • Dexamethasone
📍

Where

1 site
University of Tennessee Medical Center
Knoxville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy